Orient Europharma Co., Ltd.(TW:4120)
NT$44.90+0.55 (+1.24%)
TW:4120
Orient Europharma Co., Ltd. financials statements
NT$44.90
At close:+0.55 (+1.24%)
Orient Europharma Co., Ltd. (4120) Financial Statements
Orient Europharma Co., Ltd. Financial Overview
Orient Europharma Co., Ltd.'s market cap is currently NT$3.85B. The company's EPS TTM is NT$-6.65; its P/E ratio is -6.75; and it has a dividend yield of 8.91%. Orient Europharma Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | NT$ 4.60B | NT$ 4.39B | NT$ 4.59B | NT$ 4.73B | NT$ 4.77B |
| Gross Profit | NT$ 2.10B | NT$ 2.07B | NT$ 2.15B | NT$ 2.03B | NT$ 2.15B |
| Operating Income | NT$ -310.54M | NT$ 13.32M | NT$ 84.55M | NT$ -259.00M | NT$ -57.77M |
| EBITDA | NT$ -121.76M | NT$ 183.90M | NT$ 596.88M | NT$ -34.15M | NT$ 133.32M |
| Net Income | NT$ -567.39M | NT$ -283.93M | NT$ 143.94M | NT$ -310.80M | NT$ 120.17M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | NT$ 2.12B | NT$ 1.89B | NT$ 2.14B | NT$ 1.95B | NT$ 2.06B |
| Total Assets | NT$ 12.21B | NT$ 11.57B | NT$ 10.81B | NT$ 10.43B | NT$ 9.40B |
| Total Debt | NT$ 3.27B | NT$ 4.23B | NT$ 4.84B | NT$ 5.03B | NT$ 4.23B |
| Net Debt | NT$ 1.28B | NT$ 2.80B | NT$ 3.11B | NT$ 3.23B | NT$ 2.27B |
| Total Liabilities | NT$ 4.85B | NT$ 5.75B | NT$ 6.65B | NT$ 6.99B | NT$ 5.95B |
| Stockholders' Equity | NT$ 6.29B | NT$ 5.16B | NT$ 3.51B | NT$ 2.93B | NT$ 2.94B |
| Cash Flow | |||||
| Free Cash Flow | NT$ -472.30M | NT$ -221.31M | NT$ 20.28M | NT$ -859.84M | NT$ -1.49B |
| Operating Cash Flow | NT$ -298.63M | NT$ -121.11M | NT$ 120.98M | NT$ -218.75M | NT$ 77.65M |
| Investing Cash Flow | NT$ 1.62B | NT$ 465.20M | NT$ 62.11M | NT$ -611.56M | NT$ -1.50B |
| Financing Cash Flow | NT$ -1.05B | NT$ -760.92M | NT$ -209.71M | NT$ 428.31M | NT$ 1.36B |
Currency in TWD
